AlphaYou
Overview
Smart money at a glance
Filings to Sep 26, 2026Net selling: insiders sold $765K and bought $108K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$657K netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 2 added, 2 cutEven
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Sep 25- Open
- $35.90
- 52-wk high
- $42.81
- High
- $36.22
- 52-wk low
- $22.56
- Low
- $35.72
- Prev close
- $36.00
- Mkt cap
- $4.25B
- P/E
- 12.9x
- Volume
- 1.08M
- Fwd P/E
- 9.5x
- Beta
- 1.11
- P/S
- 3.2x
- P/B
- 145.3x
- Profit margin
- +26.8%
- Op margin
- +46.9%
- ROE
- +12.2%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about INDV filings
Are insiders buying or selling Indivior PLC Ordinary Shares (INDV) stock?
Net selling: insiders sold $765K and bought $108K of INDV stock on the open market in the 90 days to Sep 26, 2026, according to SEC Form 4 filings. $765K of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Heidbreder, Christian (Chief Scientific Officer), who sold $765K. The latest filing was on Aug 27, 2026.
Which members of Congress have traded INDV recently?
None. No member of Congress disclosed a INDV trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this INDV smart-money data?
This summary uses filings available on Sep 26, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (1)
- P7
Point72
$48.4M
added
Sells/Trims (2)
- MI
Millennium
$54.0M
trimmed
- JC
JPMorgan Chase
$4.2M
trimmed
What insiders are doing
Buys (2)
- AW
Anderson Woodrow D
$54K
bought
- AW
Anderson Woodrow D
$54K
bought
Sells (1)
- HC
Heidbreder Christian
$765K
sold
How top traders are positioned
No tracked top-trader positions in INDV right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings came in 18.6% above what analysts expected.
Earnings per share
$0.97 expected
Reports Oct 29, 2026, in 33 days
Estimates as of Sep 20, 2026
EPS expected
$1.09 to $1.15
Revenue expected
2 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $314.0M | $358.0M | $317.0M | $343.0M |
| Cost of what it sold | $62.0M | $64.0M | $40.0M | $49.0M |
| Gross profit | $252.0M | $294.0M | $277.0M | $294.0M |
| What it spent | ||||
| Research and development | $20.0M | $17.0M | $16.0M | $12.0M |
| Sales and admin | $155.0M | $223.0M | $124.0M | $122.0M |
| Other operating costs | -$22.0M | -$68.0M | — | — |
| Total operating expenses | $153.0M | $172.0M | $140.0M | $134.0M |
| What was left | ||||
| Operating profit | $99.0M | $122.0M | $137.0M | $160.0M |
| Interest on debt | $12.0M | $6.0M | $7.0M | $2.0M |
| Profit before tax | $37.0M | $81.0M | $115.0M | $160.0M |
| Tax | -$5.0M | -$21.0M | $26.0M | $38.0M |
| Net profit | $42.0M | $102.0M | $89.0M | $122.0M |
| EBITDA | $54.0M | $92.0M | $124.0M | $162.0M |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
80 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
Indivior stock carries a USD 8.13 special dividend
BullishSep 25Indivior stock heads into the open after a 0.14 percent fall
NeutralSep 25Addex Regains Rights to GABAB Positive Allosteric Modulator Portfolio from Indivior
NeutralSep 25Indivior stock heads into the open after a 0.77 percent drop
Leans bearishSep 24Indivior Pharmaceuticals stock reports USD 8.13 special dividend
Leans bullishSep 23Indivior stock heads into the open after closing at USD 34.88
NeutralSep 23Indivior stock stands at USD 34.88 below analyst targets
Leans bullishSep 22Indivior stock heads into the open after a flat Nasdaq close
Leans bullishSep 21